345 related articles for article (PubMed ID: 27109096)
1. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
[TBL] [Abstract][Full Text] [Related]
2. ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.
Khan IA; Yoo BH; McPhee M; Masson O; Surette A; Dakin-Hache K; Younis T; Bethune G; Rosen KV
Breast Cancer Res; 2018 Dec; 20(1):151. PubMed ID: 30545388
[TBL] [Abstract][Full Text] [Related]
3. ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth.
Liu X; Chipurupalli S; Jiang P; Tavasoli M; Yoo BH; McPhee M; Mazinani S; Francia G; Kerbel RS; Rosen KV
Cell Death Dis; 2022 Aug; 13(8):687. PubMed ID: 35933456
[TBL] [Abstract][Full Text] [Related]
4. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells.
Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ
J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114
[TBL] [Abstract][Full Text] [Related]
5. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment.
Rayavarapu RR; Heiden B; Pagani N; Shaw MM; Shuff S; Zhang S; Schafer ZT
J Biol Chem; 2015 Apr; 290(14):8722-33. PubMed ID: 25681438
[TBL] [Abstract][Full Text] [Related]
6. Mek activity is required for ErbB2 expression in breast cancer cells detached from the extracellular matrix.
Khan IA; Yoo BH; Rak J; Rosen KV
Oncotarget; 2017 Dec; 8(62):105383-105396. PubMed ID: 29285258
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic ras-induced down-regulation of pro-apoptotic protease caspase-2 is required for malignant transformation of intestinal epithelial cells.
Yoo BH; Wang Y; Erdogan M; Sasazuki T; Shirasawa S; Corcos L; Sabapathy K; Rosen KV
J Biol Chem; 2011 Nov; 286(45):38894-903. PubMed ID: 21903589
[TBL] [Abstract][Full Text] [Related]
8. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.
Chang J; Nicolau MM; Cox TR; Wetterskog D; Martens JW; Barker HE; Erler JT
Breast Cancer Res; 2013; 15(4):R67. PubMed ID: 23971878
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2.
Karakashev SV; Reginato MJ
Oncotarget; 2015 Feb; 6(4):1967-80. PubMed ID: 25596742
[TBL] [Abstract][Full Text] [Related]
10. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.
Reginato MJ; Mills KR; Paulus JK; Lynch DK; Sgroi DC; Debnath J; Muthuswamy SK; Brugge JS
Nat Cell Biol; 2003 Aug; 5(8):733-40. PubMed ID: 12844146
[TBL] [Abstract][Full Text] [Related]
11. Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
Corkery DP; Clarke LE; Gebremeskel S; Salsman J; Pinder J; Le Page C; Meunier L; Xu Z; Mes-Masson AM; Berman JN; Johnston B; Dellaire G
Oncogene; 2018 Jan; 37(2):174-184. PubMed ID: 28892043
[TBL] [Abstract][Full Text] [Related]
12. The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.
Whelan KA; Schwab LP; Karakashev SV; Franchetti L; Johannes GJ; Seagroves TN; Reginato MJ
J Biol Chem; 2013 May; 288(22):15865-77. PubMed ID: 23585570
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
Yoon SO; Shin S; Lipscomb EA
Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
[TBL] [Abstract][Full Text] [Related]
14. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
15. SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.
Lauricella M; Ciraolo A; Carlisi D; Vento R; Tesoriere G
Biochimie; 2012 Feb; 94(2):287-99. PubMed ID: 21835222
[TBL] [Abstract][Full Text] [Related]
16. Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.
Surette A; Yoo BH; Younis T; Matheson K; Rameh T; Snowdon J; Bethune G; Rosen KV
Breast Cancer Res Treat; 2021 Jun; 187(3):743-758. PubMed ID: 33728523
[TBL] [Abstract][Full Text] [Related]
17. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
Zhan L; Xiang B; Muthuswamy SK
Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
[TBL] [Abstract][Full Text] [Related]
19. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
Asp N; Pust S; Sandvig K
Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor protein kinase Chk2 is a mediator of anoikis of intestinal epithelial cells.
Yoo BH; Berezkin A; Wang Y; Zagryazhskaya A; Rosen KV
Int J Cancer; 2012 Jul; 131(2):357-66. PubMed ID: 21834075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
